Oliver Daltrop
Chief Tech/Sci/R&D Officer at MOONLAKE IMMUNOTHERAPEUTICS
Profile
Oliver Daltrop is currently the Chief Technical Officer at Moonlake Immunotherapeutics AG and MoonLake Immunotherapeutics.
Prior to this, he worked as the Head-Biopharma Development Transformation at Sandoz, Inc. from 2020 to 2021.
Mr. Daltrop holds a doctorate degree from the University of Oxford and an undergraduate degree from the University of Bristol.
Oliver Daltrop active positions
| Companies | Position | Start |
|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Chief Tech/Sci/R&D Officer | 31/08/2021 |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Chief Tech/Sci/R&D Officer | 31/08/2021 |
Former positions of Oliver Daltrop
| Companies | Position | End |
|---|---|---|
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Corporate Officer/Principal | 31/07/2021 |
Training of Oliver Daltrop
| University of Bristol | Undergraduate Degree |
| University of Oxford | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Health Technology |
| Private companies | 2 |
|---|---|
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Health Technology |
Sandoz, Inc.
Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Oliver Daltrop
